Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Bionano Genomics, Inc. (BNGO)

1.1   0.01 (0.92%) 03-24 16:00
Open: 1.07 Pre. Close: 1.09
High: 1.13 Low: 1.06
Volume: 2,912,973 Market Cap: 337(M)

Technical analysis

as of: 2023-03-24 4:24:29 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 1.59     One year: 1.81
Support: Support1: 1.05    Support2: 0.88
Resistance: Resistance1: 1.36    Resistance2: 1.54
Pivot: 1.19
Moving Average: MA(5): 1.1     MA(20): 1.22
MA(100): 1.76     MA(250): 1.89
MACD: MACD(12,26): -0.2     Signal(9): -0.2
Stochastic oscillator: %K(14,3): 8.2     %D(3): 10
RSI: RSI(14): 33
52-week: High: 4.34  Low: 1.05
Average Vol(K): 3-Month: 6,448 (K)  10-Days: 5,332 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ BNGO ] has closed above bottom band by 23.2%. Bollinger Bands are 42.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.13 - 1.14 1.14 - 1.14
Low: 1.05 - 1.05 1.05 - 1.06
Close: 1.09 - 1.1 1.1 - 1.11

Company Description

Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.

Headline News

Fri, 24 Mar 2023
Bionano Genomics Inc. (BNGO) Stock: A Guide to the Market Trend - The News Heater

Wed, 22 Mar 2023
Bionano Announces First Study Using OGM to Discover Structural Variants with Potential Relevance to Genetic Diagnosis of MRKH Syndrome, a Syndrome Impacting Reproductive System Development in 1 in 4,500 Females - Yahoo Finance

Tue, 21 Mar 2023
What is Bionano Genomics Inc. (BNGO) Stock Return on ... - SETE News

Mon, 20 Mar 2023
BioNano Genomics Inc (BNGO) has fallen -11.11% in a Week, Should You Hold? - InvestorsObserver

Fri, 17 Mar 2023
BioNano Genomics Inc (BNGO) has risen 3.48% Friday In Premarket Trading - InvestorsObserver

Mon, 13 Mar 2023
Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Featuring OGM Utility Across a Broad Range of Research Applications - Yahoo Finance

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. 306 (M)
Shares Float 301 (M)
% Held by Insiders 1.8 (%)
% Held by Institutions 27.8 (%)
Shares Short 57,650 (K)
Shares Short P.Month 52,260 (K)

Stock Financials

EPS -0.42
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.83
Profit Margin (%) 0
Operating Margin (%) -466.1
Return on Assets (ttm) -23.7
Return on Equity (ttm) -45.3
Qtrly Rev. Growth 30.3
Gross Profit (p.s.) 0.01
Sales Per Share 0.09
EBITDA (p.s.) -0.4
Qtrly Earnings Growth 0
Operating Cash Flow -125 (M)
Levered Free Cash Flow -61 (M)

Stock Valuations

PE Ratio -2.62
PEG Ratio 0
Price to Book value 1.3
Price to Sales 12.11
Price to Cash Flow -2.7

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.